Clinical trial

A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non…

NCT00426868 · Cytori Therapeutics, Industry · Completed

Key facts

NCT number NCT00426868
Title A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium
Official title A Randomized Clinical Trial of adiPose-deRived stEm & Regenerative Cells In the Treatment of Patients With Non revaScularizable ischEmic Myocardium - The PRECISE Trial
Lead sponsor Cytori Therapeutics, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Ischemic Heart Disease, Coronary Arteriosclerosis, Cardiovascular Disease, Coronary Disease, Coronary Artery Disease
Intervention type Other
Interventions Direct injection of ADRCs into the Left Ventricle, Direct injection of placebo into the Left Ventricle
Enrollment 27
Start date Jan 1, 2007
Primary completion Mar 1, 2012
Completion Mar 1, 2012
First posted Jan 25, 2007
Last update posted Aug 28, 2013
Countries Denmark, Netherlands, Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies